Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Clinical use of aromatase inhibitors in the treatment of breast cancers
Andrea Manni
Department of Medicine
Division of Endocrinology and Diabetes
Penn State Cancer Institute
Cancer Institute, Cancer Control
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical use of aromatase inhibitors in the treatment of breast cancers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Application
100%
Breast Cancer Treatment
100%
Aromatase Inhibitors
100%
Antitumor Action
75%
Estrogen
50%
Breast Cancer
50%
Estrogen Production
50%
Aminoglutethimide
50%
Aromatase Enzyme
50%
Estrogen Biosynthesis
50%
Cortisol
25%
Postmenopausal Women
25%
Enhanced Activity
25%
Androgens
25%
Effective Means
25%
Cytochrome P450 (CYP450)
25%
Phase II Trial
25%
Third Generation
25%
Endocrine Therapy
25%
Human Breast Cancer
25%
Aromatization
25%
Peripheral Tissues
25%
Non-steroidal
25%
Glucocorticoid Administration
25%
Conventional Dose
25%
Steroidogenic Enzymes
25%
Adrenalectomy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Aromatase Inhibitor
100%
Aromatase
50%
Aminoglutethimide
50%
Tamoxifen
25%
Hydrocortisone
25%
Androgen
25%
Cytochrome P450
25%
Endocrine Therapy
25%
Glucocorticoid
25%